Decree-Law No. 23/2025: New Rules for Cosmetic Products in Portugal
Decree-Law no. 23/2025 has been published, ensuring the implementation of Regulation (EC) no. 1223/2009 on cosmetic products. The decree comes into force on March 24, 2025 and establishes new rules to guarantee the safety of cosmetics on the Portuguese market.
ELS Group Named Finalist for the 2025 Sindusfarma Quality Award in Two Categories
ELS Group has been selected as a finalist for the 2025 Sindusfarma Quality Award in Quality Control Consulting and Storage & Distribution of Medicines. This recognition highlights the company’s expertise and commitment to excellence in the Brazilian pharmaceutical sector.
EMA and HMA Present Strategy for Medicines Regulation in the European Union until 2028
The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) recently unveiled the new European Medicines Agency Network Strategy to 2028 (EMANS 2028), a document that outlines the priorities for medicines regulation in the European Union in the coming years. This strategy aims to respond to the challenges and needs of the pharmaceutical sector and strengthen the EU’s competitiveness in the development and manufacture of medicines, while ensuring safe and equitable access to innovative treatments.
Portugal is the second-largest exporter of medicinal cannabis in 2024
Portugal has already exported 18,521 kg of medicinal cannabis, and aims to reach 25 tons by the end of 2024.
EMA launches a public consultation on the use of real-world data in the regulation of medicines.
The EMA opens a public consultation on the use of data in the regulation of medicines under the Data Quality Framework for the Regulation of Medicines.